MedTrace Logo

Pharmacological Treatment - An Overview of Its Role in Managing Childhood Obesity

NCT07304141 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 128

Last updated 2026-02-27

No results posted yet for this study

Summary

The aim of the study is to examine the effects of pharmacological treatment for obesity on BMI trajectories and metabolic markers among patients in routine clinical care. A retrospective observational study. By collecting and analysing real-life data from the first children and adolescents in Sweden who have been offered pharmacological treatment for obesity, the results can contribute to a better understanding of how these treatments function in practice.

Conditions

  • Obesity (Disorder)
  • Child Obesity

Interventions

OTHER

Liraglutide 3 mg (Saxenda)

This is a retrospective observational study of adolescents aged 10-18 years with obesity who were offered liraglutide treatment at the Pediatric Clinic in Region Halland and at the Regional Childhood Obesity Center, Queen Silvia's Children's Hospital, Sahlgrenska University Hospital.

Sponsors & Collaborators

  • Göteborg University

    lead OTHER

Eligibility

Min Age
10 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-20
Primary Completion
2025-12-12
Completion
2025-12-12

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07304141 on ClinicalTrials.gov